Search results
Non-steroidal anti-inflammatory drugs [1] [3] ( NSAID) [1] are members of a therapeutic drug class which reduces pain, [4] decreases inflammation, decreases fever, [1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds ...
Rickettsia rickettsii. Brumpt, 1922. Rickettsia rickettsii is a Gram-negative, intracellular, coccobacillus bacterium that was first discovered in 1902. [1] Having a reduced genome, the bacterium harvests nutrients from its host cell to carry out respiration, making it an organoheterotroph. Maintenance of its genome is carried out through ...
Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. [10] Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. [1] [2] [11] It primarily affects skin with a relatively high number of oil glands ...
Doxycycline. Doxycycline: (Doryx®, Doxyhexal®, Doxylin®, among others) is a tetracycline-based antibiotic, 100 mg orally twice/day for 7–14 days, uses Tetracycline-Controlled Transcriptional Activation as a method of inducible gene expression that disrupts protein translation in bacteria, thereby damaging the ability of microbes to grow and repair;
Antimalarial medication. Antimalarial medications or simply antimalarials are a type of antiparasitic chemical agent, often naturally derived, that can be used to treat or to prevent malaria, in the latter case, most often aiming at two susceptible target groups, young children and pregnant women. [1]
Infectious disease, hematology. Eosinophilia is a condition in which the eosinophil count in the peripheral blood exceeds 5 × 10 8 /L (500/μL). [1] Hypereosinophilia is an elevation in an individual's circulating blood eosinophil count above 1.5 × 10 9 / L (i.e. 1,500/ μL ). The hypereosinophilic syndrome is a sustained elevation in this ...
Cytochrome P450 2C19 (abbreviated CYP2C19) is an enzyme protein. It is a member of the CYP2C subfamily of the cytochrome P450 mixed-function oxidase system. This subfamily includes enzymes that catalyze metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs. In humans, it is the CYP2C19 gene that encodes the ...
